The role of estrogen receptor beta in breast cancer | Biomarker Research | Full Text
Fulvestrant-Induced Cell Death and Proteasomal Degradation of Estrogen Receptor α Protein in MCF-7 Cells Require the CSK c-Src Tyrosine Kinase | PLOS ONE
Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review)
New insights into acquired endocrine resistance of breast cancer
Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast Cancer | Journal of Medicinal Chemistry
Dual-mechanism estrogen receptor inhibitors | PNAS
Potentiation of ICI182,780 (Fulvestrant)-induced Estrogen Receptor-α Degradation by the Estrogen Receptor-related Receptor-α Inverse Agonist XCT790* - Journal of Biological Chemistry
Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE
Dual-mechanism estrogen receptor inhibitors | PNAS
Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE
New insights into acquired endocrine resistance of breast cancer
Estrogen receptor signaling as a target for novel breast cancer therapeutics - ScienceDirect
EREs).
Molecular mechanism of estrogen–estrogen receptor signaling - Yaşar - 2017 - Reproductive Medicine and Biology - Wiley Online Library
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)
Frontiers | Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
Estrogen signaling: An emanating therapeutic target for breast cancer treatment - ScienceDirect
Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment - Abstract - Europe PMC
Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE
Dual-mechanism estrogen receptor inhibitors | PNAS
Estrogen receptor-α signaling in post-natal mammary development and breast cancers | SpringerLink
Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy. - Abstract - Europe PMC
Impact of Apparent Antagonism of Estrogen Receptor β by Fulvestrant on Anticancer Activity of 2-Methoxyestradiol | Anticancer Research
